CLV Stock Overview
Engages in the business of manufacturing, refining, and sale of tuna oil and encapsulated products in Australia, New Zealand, Asia, Europe, and the Americas.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Clover Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.49 |
| 52 Week High | AU$1.23 |
| 52 Week Low | AU$0.42 |
| Beta | 0.42 |
| 11 Month Change | -1.98% |
| 3 Month Change | -1.00% |
| 1 Year Change | -59.09% |
| 33 Year Change | -72.65% |
| 5 Year Change | -73.46% |
| Change since IPO | 16.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLV | AU Chemicals | AU Market | |
|---|---|---|---|
| 7D | 7.6% | -0.4% | 0.2% |
| 1Y | -59.1% | -1.1% | 7.5% |
Return vs Industry: CLV underperformed the Australian Chemicals industry which returned -1.1% over the past year.
Return vs Market: CLV underperformed the Australian Market which returned 7.5% over the past year.
Price Volatility
| CLV volatility | |
|---|---|
| CLV Average Weekly Movement | 4.9% |
| Chemicals Industry Average Movement | 10.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in AU Market | 16.7% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: CLV has not had significant price volatility in the past 3 months.
Volatility Over Time: CLV's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 56 | Peter Davey | www.clovercorp.com.au |
Clover Corporation Limited engages in the business of manufacturing, refining, and sale of tuna oil and encapsulated products in Australia, New Zealand, Asia, Europe, and the Americas. The company offers docosahexaenoic acid (DHA) tuna oils under the Nu-Mega HiDHA brand name for use in infant formula and pharmaceutical products; and cold pressed and refined tuna oils under the Ocean Gold brand name. It also provides DHA powders, including Nu-Mega Driphorm powders, used in a range of infant formula, follow-on formula, growing up milks, and food applications; Nu-Mega Driphorm HA for non-dairy applications; and microencapsulation.
Clover Corporation Limited Fundamentals Summary
| CLV fundamental statistics | |
|---|---|
| Market cap | AU$83.50m |
| Earnings (TTM) | AU$1.92m |
| Revenue (TTM) | AU$62.77m |
43.0x
P/E Ratio1.3x
P/S RatioIs CLV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLV income statement (TTM) | |
|---|---|
| Revenue | AU$62.77m |
| Cost of Revenue | AU$45.56m |
| Gross Profit | AU$17.21m |
| Other Expenses | AU$15.28m |
| Earnings | AU$1.92m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.012 |
| Gross Margin | 27.41% |
| Net Profit Margin | 3.07% |
| Debt/Equity Ratio | 20.8% |
How did CLV perform over the long term?
See historical performance and comparison